Nipple-Areola Complex Sensitivity After the Section of Periareolar Dermis in Breast Reduction

April 26, 2013 updated by: Jairo Zacchê de Sá, Universidade Federal de Pernambuco
The purpose of this study is to evaluate the feasibility and sensitivity of nipple-areolar complex (NAC) prospectively due to the section of the dermis after decortication (Schwartzmann's maneuver), in 50 patients undergoing breast reduction surgery.

Study Overview

Detailed Description

Preservation of the dermis after decortication regions of the areola and periareolar is considered relevant by most plastic surgeons.

In patients whose CAP should be mobilized through large distances in order to correct breast ptosis, or in cases of dense breasts where noted little slip of skin over the breast parenchyma, the periareolar dermis causes limitation on the mobility of the NAC.

In clinical practice, there is a greater mobilization of NAC when making a careful section of the dermis after decortication. In contrast, the appearance of partial necrosis in these cases has become a rarity, as no case of total necrosis was observed.

Given the technical benefit observed due to greater mobilization, there is no report in the literature about how behaves the sensitivity of the NAC in these cases.

To evaluate the sensitivity of the NAC will be used Semmes-Weisnstein's monofilament. Each point will be obtained five measurements. The largest will be scorned and the lowest value. The final value of each point corresponds to an arithmetic mean of the three remaining values.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pernambuco
      • Recife, Pernambuco, Brazil, 50670-607
        • Hospital das Clínicas da UFPE
        • Contact:
        • Principal Investigator:
          • Jairo Z Sá, surgeon

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients who willingly seek the service requesting breast reduction or mastopexy;
  • Patients who after consultation with the surgeon who led the research presents realistic expectation, being safe with the possible outcome of the surgery;
  • Patients who undertake to comply with the protocol previously presented and discussed with them;

Exclusion Criteria:

  • Patients with prior breast surgery;
  • Patients with body mass index (BMI) greater than 34.9;
  • Patients with severe anemia;
  • Patients with neurological disease;
  • Patients with impairment cardiovascular;
  • Metabolic diseases - diabetes;
  • Patients with autoimmune disease;
  • Menopausal patients
  • Patients with collagen disease;
  • Patients with psychiatric disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Section of Periareolar Dermis
Other Names:
  • Decortication
  • Sensitivity
  • Nipple-Areolar Complex (NAC)
  • Breast Reduction
  • Schwartzmann's Maneuver

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nipple-Areola Complex (NAC) Sensitivity
Time Frame: 3 weeks
To evaluate the sensitivity of the NAC in breast reduction
3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nipple-Areola Complex (NAC) sensitivity
Time Frame: 6 weeks
To evaluate the sensitivity of the NAC in breast reduction
6 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nipple-Areola Complex sensitivity
Time Frame: 12 months
To evaluate the sensitivity of the NAC in breast reduction
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jairo Z Sá, surgeon, Hospital das Clínicas da Universidade Federal de Pernambuco

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Anticipated)

June 1, 2014

Study Completion (Anticipated)

June 1, 2015

Study Registration Dates

First Submitted

February 4, 2013

First Submitted That Met QC Criteria

February 8, 2013

First Posted (Estimate)

February 12, 2013

Study Record Updates

Last Update Posted (Estimate)

April 29, 2013

Last Update Submitted That Met QC Criteria

April 26, 2013

Last Verified

April 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UFPE (CAAE N. 79139717.6.0000.5208)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sensitivity of Nipple-areolar Complex

Clinical Trials on Section of Periareolar Dermis in Breast Reduction.

3
Subscribe